Aortech International PLC
13 January 2003
AORTECH INTERNATIONAL PLC
Sale of Heart Valve Business
AorTech International plc ('the Company') announced on 6 January 2003 a change
in strategic direction. The Board has concluded that it will concentrate future
activity on the Company's biomaterials business and on its development programme
for the polymer heart valve. As a result, the Company announces today the sale
of its commercial heart valve business to the Koehler Chemie GmbH group of
Alsbach, Germany, a privately owned pharmaceutical group founded in 1959.
The brands involved comprise Ultracor Mechanical Prosthesis, Aspire Stentless
Prosthesis, Elan Aortic Stentless Prosthesis, Elan Root Stentless Prosthesis and
Mitral Repair System.
Koehler Chemie is paying £2.7 million in cash for the business and will take
over management responsibility with effect from 13 January 2003.
The sale concludes an extensive search for an industry partner to manage and
develop this business, maintaining continuity of supply to customers.
During the six month period ended 30 September 2002 the business, which was loss
making, had a turnover of £0.9 million. The assets being sold have a book value
of £4.8 million comprising the inventory, fixed assets and purchased goodwill of
the commercial heart valve business.
Proceeds from the disposal will be used as working capital for the remaining
parts of the Company's business. Following the disposal, the Company's annual
rate of cash burn will be significantly reduced.
13th January 2003
ENQUIRIES:
AorTech International plc Tel: 01698 746 699
Bill Strachan, Chief Executive
Ian Cameron, Finance Director
College Hill Tel: 020 7457 2020
Nicholas Nelson
Clare Warren
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.